Interest in Amarin (NASDAQ: AMRN) mounting ahead of FDA Decision on AMR101; Takeover Speculation
Long Ideas - With the FDA action date (PDUFA date) set for July 26th, many investors are focusing on the potential approval of Amarin’s (NASDAQ: AMRN) drug to … Continue Reading
Read Now